E. T. S. Yin

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Elaine Tan Su Yin, D. Blaise, A. Nagler, 2019, Journal of Hematology & Oncology.

A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma

Elaine Tan Su Yin, He Huang, Kui Zhao, 2020, Frontiers of Medicine.

HLA‐matched allogeneic anti‐CD19 CAR‐T therapy in treating a relapsed/refractory acute lymphoblastic leukemia patient with high tumor burden

Elaine Tan Su Yin, He Huang, G. Wei, 2022, ImmunoMedicine.

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission

Elaine Tan Su Yin, He Huang, G. Wei, 2021, Frontiers in Oncology.

Combination of CRISPR/Cas9 System and CAR-T Cell Therapy: A New Era for Refractory and Relapsed Hematological Malignancies

Elaine Tan Su Yin, He Huang, Yong-xian Hu, 2021, Current Medical Science.

The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)

Elaine Tan Su Yin, Kui Zhao, Xin Zhao, 2021, BMC Medical Imaging.

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

Helen Huang, V. Jaiswal, K. Leung, 2023, Clinical cardiology.

Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion

Elaine Tan Su Yin, He Huang, Linghui Zhou, 2022, Bone Marrow Transplantation.